BMC GASTROENTEROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月大修1次后接收感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0 偏重的研究方向：胃肠道 经验分享：还在送审中，希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：脂肪肝 经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胃肠道 经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：结直肠肿瘤 经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿 拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝； 拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝 拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0 偏重的研究方向：预后;肝癌 经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]

2024-03-12 12187ebfm02暂无昵称来自贵州省

审稿很慢3个多月大修1次后接收感谢

7 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月大修1次后接收感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0 偏重的研究方向：胃肠道 经验分享：还在送审中，希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：脂肪肝 经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胃肠道 经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：结直肠肿瘤 经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿 拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝； 拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝 拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0 偏重的研究方向：预后;肝癌 经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]

2024-04-04 ms9000000143854069 来自新疆

The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review

6 0

[GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月大修1次后接收感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0 偏重的研究方向：胃肠道 经验分享：还在送审中，希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：脂肪肝 经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胃肠道 经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：结直肠肿瘤 经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿 拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝； 拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝 拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0 偏重的研究方向：预后;肝癌 经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]

2023-08-10 152608_3287 来自江西省

投稿命中率:50.0
偏重的研究方向：胃肠道
经验分享：还在送审中，希望发表

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月大修1次后接收感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0 偏重的研究方向：胃肠道 经验分享：还在送审中，希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：脂肪肝 经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胃肠道 经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：结直肠肿瘤 经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿 拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝； 拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝 拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0 偏重的研究方向：预后;肝癌 经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]

2024-03-06 ms5000000189258852 来自广东省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：脂肪肝
经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。

8 0

[GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月大修1次后接收感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0 偏重的研究方向：胃肠道 经验分享：还在送审中，希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：脂肪肝 经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胃肠道 经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：结直肠肿瘤 经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿 拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝； 拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝 拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0 偏重的研究方向：预后;肝癌 经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]

2023-11-23 152608_3287 来自江西省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：胃肠道
经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月大修1次后接收感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0 偏重的研究方向：胃肠道 经验分享：还在送审中，希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：脂肪肝 经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胃肠道 经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：结直肠肿瘤 经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿 拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝； 拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝 拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0 偏重的研究方向：预后;肝癌 经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]

2023-11-15 10e45bd6m59暂无昵称来自美国

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：结直肠肿瘤
经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀

26 0

[GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月大修1次后接收感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0 偏重的研究方向：胃肠道 经验分享：还在送审中，希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：脂肪肝 经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胃肠道 经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：结直肠肿瘤 经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿 拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝； 拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝 拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0 偏重的研究方向：预后;肝癌 经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]

2023-08-26 ms5000000089678974 来自江苏省

BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？

41 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月大修1次后接收感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0 偏重的研究方向：胃肠道 经验分享：还在送审中，希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：脂肪肝 经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胃肠道 经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：结直肠肿瘤 经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿 拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝； 拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝 拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0 偏重的研究方向：预后;肝癌 经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]

2023-06-20 ms2000000713462597 来自江西省

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：单基因泛癌分析;生信
经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿
拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝；
拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝
拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。

45 0

[GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月大修1次后接收感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0 偏重的研究方向：胃肠道 经验分享：还在送审中，希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：脂肪肝 经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胃肠道 经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：结直肠肿瘤 经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿 拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝； 拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝 拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0 偏重的研究方向：预后;肝癌 经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]

2023-04-25 1481eb82m89暂无昵称来自北京

审稿速度:2.0 | 投稿命中率:50.0
经验分享：编辑的审稿意见比较友好

47 0

[GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月大修1次后接收感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思，是外审了嘛还是在编辑呢里。详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0 偏重的研究方向：胃肠道 经验分享：还在送审中，希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：脂肪肝 经验分享：一周返修意见回来，返修时间两周，回复后，等一个月就直接录用，总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胃肠道 经验分享：太恶心的杂志了，大修之后还找了不一样的审稿人，而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：结直肠肿瘤 经验分享：时间比较长，但感觉审稿人比较友好，不着急的话，可以试试，稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：单基因泛癌分析;生信 经验分享：非常非常慢，途中催稿过2次，半年多后直接给出拒稿 拒稿理由1：研究老套、研究不够深、专业生信人员分析很快得出类似研究，直接拒绝； 拒稿理由2：要求上传低版本的word，要不然阅读出现重叠错误；前言没有肿瘤的流行背景，研究常见，拒绝 拒稿理由3：理由点很多，比较细节，有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0 偏重的研究方向：预后;肝癌 经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]

2023-04-20 zzyt981 来自北京

审稿速度:12.0
偏重的研究方向：预后;肝癌
经验分享：2022年6月投稿，2023年4月20日接收，经历了一次修改

61 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务